The Discounted Cash Flow (DCF) valuation of Biomarin Pharmaceutical Inc (BMRN) is 16.53 USD. With the latest stock price at 65.97 USD, the upside of Biomarin Pharmaceutical Inc based on DCF is -74.9%.
| Range | Selected | |
| WACC / Discount Rate | 6.6% - 8.3% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 10.43 - 36.60 | 16.53 |
| Upside | -84.2% - -44.5% | -74.9% |